Showing results (71-80 of 84) with videos related to
Sort By:
Pageof 9
Blood Advances|May 5, 2023
Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national studyGregory A Abel, Donnie Hebert, Cecilia Lee, et al.Clinical Lung Cancer|August 19, 2020
Phase II Study of Immunotherapy With Tecemotide and Bevacizumab After Chemoradiation in Patients With Unresectable Stage III Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC): A Trial of the ECOG-ACRIN Cancer Research Group (E6508)Jyoti D Patel, Ju-Whei Lee, David P Carbone, et al.Journal of the American Geriatrics Society|March 30, 2019
Quality of Life of Caregivers of Older Patients with Advanced CancerLee A Kehoe, Huiwen Xu, Paul Duberstein, et al.Cancer|October 9, 2020
Patient and caregiver agreement on prognosis estimates for older adults with advanced cancerKah Poh Loh, Enrique Soto Pérez de Celis, Paul R Duberstein, et al.Journal of Thrombosis and Haemostasis : JTH|March 27, 2024
Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trialRobert D McBane, Charles L Loprinzi, Tyler Zemla, et al.JAMA Network Open|February 18, 2022
Association of Prognostic Understanding With Health Care Use Among Older Adults With Advanced Cancer: A Secondary Analysis of a Cluster Randomized Clinical TrialKah Poh Loh, Christopher L Seplaki, Chandrika Sanapala, et al.Blood Advances|August 8, 2023
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapiesEdward J Gorak, Michael Otterstatter, Tareq Al Baghdadi, et al.JCO Oncology Practice|January 22, 2024
Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALLJulie A Wolfson, Allison C Grimes, Michelle Nuno, et al.JAMA Oncology|November 8, 2019
Communication With Older Patients With Cancer Using Geriatric Assessment: A Cluster-Randomized Clinical Trial From the National Cancer Institute Community Oncology Research ProgramSupriya G Mohile, Ronald M Epstein, Arti Hurria, et al.Blood Advances|February 11, 2026
A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History StudyAmy E DeZern, Nancy Gillis, Michael Otterstatter, et al.Pageof 9